[HTML][HTML] Targeting breast cancer signaling via phytomedicine and nanomedicine

JA Ansari, JA Malik, S Ahmed, FA Bhat, A Khanam… - Pharmacology, 2023 - karger.com
Background: The development of breast cancer (BC) and how it responds to treatment have
both been linked to the involvement of inflammation. Chronic inflammation is critical in …

Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro …

A Sartaj, Annu, M Alam, L Biswas, MS Yar… - Journal of Drug …, 2022 - Taylor & Francis
Purpose The current research investigated the development and evaluation of dual drug-
loaded nanostructure lipidic carriers (NLCs) of green tea extract and Ribociclib. Method In …

Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast …

A Sartaj, S Baboota, J Ali - Journal of Drug Delivery Science and …, 2021 - Elsevier
Breast cancer is the most common among all types of cancers and the second-leading
position of death worldwide. It also the most general classification of malignant neoplasms …

[PDF][PDF] Synthesis and anticancer evaluation of 2-oxo-2-(arylamino) ethyl 4-phenylpiperazine-1-carbodithioates

F Hafeez, AF Zahoor, A Rasul, S Ahmad… - Pak. J. Pharm …, 2021 - researchgate.net
Piperazine moiety is found as an efficient pharmacological scaffold in various drugs. To
explore the anticancer potential of piperazine framework, a series of novel N-acetamides …

Carbon-based nanoparticles and dendrimers for delivery of combination drugs

KM Ranch, MR Shukla, FA Maulvi, DT Desai - Nanocarriers for the Delivery …, 2021 - Elsevier
Combinatorial drug delivery for advanced stage cancer is being widely studied and utilized
in the clinical as well as research setups. They have become an undeterring part of the …